Infections: all 6,702 studies

Page 14 of 68. Open to participants first (801), then studies with results posted, then the rest; newest registration first within each.

• Hand Hygiene and Hospital Acquired InfectionsCompletedNCT02252562Not applicableResults posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination (FDC) for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic HCV InfectionCompletedNCT02251717Phase 2Results posted
• Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and AdolescentsCompletedNCT02250274Phase 4Results posted
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-InfectionCompletedNCT02249182Phase 2Results posted
• Implementation of a Molecular Diagnostic for Pediatric Acute Gastroenteritis: The FilmArray GI Panel IMPACT StudyCompletedNCT02248285Not applicableResults posted
• HCV-HIV Co-infected Patient Cohort in ThailandCompletedNCT02247440Phase 4Results posted
• Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in EgyptCompletedNCT02247401Phase 3Results posted
• Prevention of Necrotizing Enterocolitis of Premature Newborns Under Less Than 1500 g Using ProbioticsCompletedNCT02245815Not applicableResults posted
• Wood Stove Interventions and Child Respiratory HealthCompletedNCT02240134Not applicableResults posted
• Plerixafor Versus G-CSF in the Treatment of People With WHIM SyndromeCompletedNCT02231879Phase 2/3Results posted
• Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral NutritionTerminatedNCT02227329Phase 1/2Results posted
• Ledipasvir/Sofosbuvir Fixed-Dose Combination and Vedroprevir With or Without Ribavirin in Treatment-Experienced Participants With Chronic Genotype 1 HCV Infection and CirrhosisCompletedNCT02226549Phase 2Results posted
• Building an Optimal Hand Hygiene BundleCompletedNCT02223455Not applicableResults posted
• Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV InfectionCompletedNCT02220998Phase 3Results posted
• Ledipasvir/Sofosbuvir Fixed-Dose Combination on Cerebral Metabolism and Neurocognition in Treatment-Naive and Treatment-Experienced Participants With Chronic Genotype 1 HCV InfectionCompletedNCT02219685Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and CirrhosisCompletedNCT02219503Phase 3Results posted
• A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT02219490Phase 3Results posted
• A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) InfectionCompletedNCT02216422Phase 3Results posted
• Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.TerminatedNCT02202135Phase 3Results posted
• Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV InfectionCompletedNCT02201953Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV InfectionCompletedNCT02201940Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B CirrhosisCompletedNCT02201901Phase 3Results posted
• Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract InfectionTerminatedNCT02198833Not applicableResults posted
• Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral TherapyTerminatedNCT02194998Phase 2Results posted
• Antibiotic Irrigation for PancreatoduodenectomyCompletedNCT02186457Not applicableResults posted
• Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02185794Phase 1Results posted
• S. Aureus Screening and DecolonizationCompletedNCT02182115Phase 4Results posted
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionCompletedNCT02178592Phase 3Results posted
• Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV InfectionCompletedNCT02175758Phase 2Results posted
• Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in AdultsCompletedNCT02168946Phase 3Results posted
• A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT02167945Phase 3Results posted
• Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and APCompletedNCT02166476Phase 3Results posted
• Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic PatientsCompletedNCT02158442Phase 2Results posted
• AUGMENTIN™ in Dental InfectionsCompletedNCT02141217Phase 4Results posted
• Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)CompletedNCT02137772Phase 3Results posted
• Fast Track Appendectomy for Suppurative AppendicitisCompletedNCT02137603Not applicableResults posted
• Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT02136797Phase 2Results posted
• Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) InfectionCompletedNCT02135614Phase 2Results posted
• Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsCompletedNCT02135419Phase 3Results posted
• The Influence of Chronic CMV Infection on Influenza Vaccine ResponsesCompletedNCT02134184Phase 4Results posted
• Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) InfectionCompletedNCT02128217Phase 1Results posted
• Single Dose vs. Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT02127970Phase 3Results posted
• A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult SubjectsCompletedNCT02120352Phase 2Results posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without CirrhosisCompletedNCT02114177Phase 3Results posted
• Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and CirrhosisCompletedNCT02114151Phase 3Results posted
• A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge PatientsCompletedNCT02111564Phase 3Results posted
• Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell TransplantCompletedNCT02108522Not applicableResults posted
• Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) With or Without Ribavirin for Participants With Hepatitis C Genotype 1, 4, or 6 Infections Who Have Failed Prior Treatment With Pegylated Interferon + Ribavirin (MK-5172-068)CompletedNCT02105701Phase 3Results posted
• Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus InfectionCompletedNCT02087306Phase 3Results posted
• Evaluation of the Strip PeriScreen for the Fast Diagnosis of the Spontaneous Infection of the Liquid of Ascites During the CirrhosisCompletedNCT02085915Not applicableResults posted
• Safety, Pharmacokinetics, and Pharmacodynamics of Ruzasvir (MK-8408) in Participants With Hepatitis C Infection (MK-8408-003)CompletedNCT02076100Phase 1Results posted
• ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus InfectionCompletedNCT02075593Phase 3Results posted
• Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV InfectionCompletedNCT02074514Phase 3Results posted
• Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in ChildrenCompletedNCT02072174Phase 4Results posted
• Enhancement by Poly-ICLC During HIV-1 InfectionCompletedNCT02071095Phase 1/2Results posted
• Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT02066402Phase 3Results posted
• Active Bathing to Eliminate Infection (ABATE Infection) TrialCompletedNCT02063867Not applicableResults posted
• Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy SubjectsCompletedNCT02061358Phase 1Results posted
• OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic FibrosisCompletedNCT02054156Phase 3Results posted
• Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile InfectionTerminatedNCT02053350Phase 2Results posted
• AIDS 347: IL-6 Blockade in Treated HIV InfectionCompletedNCT02049437Phase 1/2Results posted
• Autologous Fecal TherapyCompletedNCT02046525Phase 2Results posted
• Probiotics to Promote Intestinal HealthCompletedNCT02046512Phase 4Results posted
• Dose-Ranging Study of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT02045797Phase 2Results posted
• Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)CompletedNCT02037984Phase 1/2Results posted
• A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric ParticipantsCompletedNCT02034162Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT02023099Phase 3Results posted
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV InfectionCompletedNCT02021656Phase 3Results posted
• Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV InfectionCompletedNCT02021643Phase 3Results posted
• Negative Pressure Wound Therapy for Prevention of Poststernotomy InfectionCompletedNCT02020018Not applicableResults posted
• Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis®CompletedNCT02016690Results posted
• Antibiotic Safety (SCAMP)CompletedNCT01994993Phase 2/3Results posted
• Seven vs. 14 Days Treatment for Male Urinary Tract InfectionCompletedNCT01994538Not applicableResults posted
• Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 PatientsCompletedNCT01989910Phase 4Results posted
• Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure InfectionsCompletedNCT01984684Phase 3Results posted
• Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV InfectionCompletedNCT01984294Phase 2Results posted
• ERADICATE Hp - Treating Helicobacter Pylori With RHB-105CompletedNCT01980095Phase 3Results posted
• Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV InfectionCompletedNCT01975675Phase 3Results posted
• PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 MonthsCompletedNCT01973439Phase 1Results posted
• ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney TransplantationCompletedNCT01972035Phase 2Results posted
• A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)CompletedNCT01970371Phase 3Results posted
• Comparison of Efficacy and Tolerability of Two Cough Syrups in Cough Due to Cold in Children.CompletedNCT01968434Phase 4Results posted
• Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) InfectionsCompletedNCT01967225Phase 3Results posted
• Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV InfectionCompletedNCT01965535Phase 2Results posted
• Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal InsufficiencyCompletedNCT01958281Phase 2Results posted
• Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal WomenCompletedNCT01958073Phase 4Results posted
• Molecular Epidemiology of Clostridium Difficile Infections in ChildrenCompletedNCT01957761Results posted
• Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.CompletedNCT01952470Phase 2Results posted
• Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV MedicationsCompletedNCT01949116Phase 2Results posted
• Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIVCompletedNCT01946139Not applicableResults posted
• Meropenem Dosage Strategy Based on PPK ModelCompletedNCT01944319Phase 4Results posted
• Intravenous Nutrition in Hospitalized Patients: Comparison of Two OilsCompletedNCT01943409Phase 4Results posted
• A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionCompletedNCT01939197Phase 2/3Results posted
• Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIVCompletedNCT01935089Phase 2Results posted
• Seroepidemiological Study of Pertussis and Other Infectious DiseasesCompletedNCT01929473Results posted
• A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.TerminatedNCT01928693Phase 2Results posted
• A Pilot Study of the WoundWand™ Debridement Device on Infection PreventionTerminatedNCT01924806Not applicableResults posted
• An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or BuprenorphineCompletedNCT01911845Phase 2Results posted
• A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)CompletedNCT01910402Phase 3Results posted
• A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of MaravirocCompletedNCT01894776Phase 1Results posted

← Infections overview